BIOXCEL THERAPEUTICS INC

CUSIP: 09075P105 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 123,077 Value ($000) $347 Avg Close — Range —
Q4 2023
Shares 126,506 Value ($000) $373 Avg Close — Range —
Q3 2023
Shares 128,022 Value ($000) $324 Avg Close — Range —
Q2 2023
Shares 113,121 Value ($000) $753 Avg Close — Range —
Q1 2023
Shares 77,132 Value ($000) $1,439 Avg Close — Range —
Q4 2022
Shares 71,949 Value ($000) $1,545 Avg Close — Range —
Q3 2022
Shares 65,219 Value ($000) $771 Avg Close — Range —
Q2 2022
Shares 60,809 Value ($000) $802 Avg Close — Range —
Q1 2022
Shares 58,386 Value ($000) $1,220 Avg Close — Range —
Q4 2021
Shares 56,749 Value ($000) $1,154 Avg Close — Range —
Q3 2021
Shares 54,171 Value ($000) $1,645 Avg Close — Range —
Q2 2021
Shares 49,669 Value ($000) $1,443 Avg Close — Range —
Q1 2021
Shares 60,484 Value ($000) $2,609 Avg Close — Range —
Q4 2020
Shares 61,820 Value ($000) $2,856 Avg Close — Range —
Q3 2020
Shares 55,597 Value ($000) $2,410 Avg Close — Range —
Q2 2020
Shares 52,453 Value ($000) $2,780 Avg Close — Range —
Q1 2020
Shares 49,854 Value ($000) $1,115 Avg Close — Range —
Q4 2019
Shares 19,423 Value ($000) $284 Avg Close — Range —
Q3 2019
Shares 19,423 Value ($000) $137 Avg Close — Range —
Q2 2019
Shares 18,083 Value ($000) $198 Avg Close — Range —